Equities

ASKA Pharmaceutical Holdings Co Ltd

ASKA Pharmaceutical Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,207.00
  • Today's Change16.00 / 0.73%
  • Shares traded88.30k
  • 1 Year change+35.98%
  • Beta1.2650
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments17,23817,90517,103
Total Receivables, Net15,57915,21714,482
Total Inventory20,40217,68715,060
Prepaid expenses------
Other current assets, total2,9242,9502,912
Total current assets56,14353,75949,557
Property, plant & equipment, net11,26310,79610,936
Goodwill, net2,1103,6735,366
Intangibles, net767792817
Long term investments15,65414,38512,223
Note receivable - long term------
Other long term assets2,1122,0162,022
Total assets90,74587,13883,297
LIABILITIES
Accounts payable7,3555,8606,841
Accrued expenses1,2251,1661,188
Notes payable/short-term debt300300300
Current portion long-term debt/capital leases4,6803,1381,423
Other current liabilities, total10,4087,1866,259
Total current liabilities23,96817,65016,011
Total long term debt4,5059,18512,323
Total debt9,48512,62314,046
Deferred income tax------
Minority interest------
Other liabilities, total3425,7706,071
Total liabilities28,81532,60534,405
SHAREHOLDERS EQUITY
Common stock1,1971,1971,197
Additional paid-in capital1,8481,8471,867
Retained earnings (accumulated deficit)56,37249,61945,833
Treasury stock - common(3287)(3350)(3479)
Unrealized gain (loss)4,7904,5903,231
Other equity, total1,010630243
Total equity61,93054,53348,892
Total liabilities & shareholders' equity90,74587,13883,297
Total common shares outstanding282828
Treasury shares - common primary issue2.232.282.38
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.